Independent Panel Finds Transgression of Fair Competition Code, Cover-Up over SIGN Trial

Ex-Tokyo High Court Judge Kunio Harada A third-party panel looking into a clinical trial involving the chronic myeloid leukemia (CML) drug Tasigna (nilotinib) has concluded that the Japanese arm of Swiss pharma titan Novartis AG violated the industry’s fair competition...read more